Nov 02, 2021 / 09:00PM GMT
Operator
Thank you for standing by, and welcome to the third quarter 2021 financial results and corporate update. (Operator Instructions). I would now like to hand the conference over to Joshua Higa. Please go ahead.
Joshua Higa - Ultragenyx Pharmaceutical Inc. - Director of IR & Corporate Communications
Good afternoon, and welcome to the Ultragenyx Financial Results and Corporate Update Conference Call for the third quarter 2021. We have issued a press release detailing our financial results, which you can find on our website at ultragenyx.com.
I am Joshua Higa, Director of Investor Relations. Joining me on this call are Emil Kakkis, Chief Executive Officer and President; Camille Bedrosian, Chief Medical Officer; Erik Harris, Chief Commercial Officer; and Mardi Dier, Chief Financial Officer.
I would like to remind investors that this call will include forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including but not limited to the types of statements identified as
Q3 2021 Ultragenyx Pharmaceutical Inc Earnings Call Transcript
Nov 03, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers